dog |
LDLo |
subcutaneous |
769ug/kg (0.769mg/kg) |
behavioral: muscle contraction or spasticity) gastrointestinal: changes in structure or function of salivary glands gastrointestinal: ulceration or bleeding from large intestine |
Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 5, Pg. 184, 1946. |
mouse |
LD50 |
intraperitoneal |
380ug/kg (0.38mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 192, Pg. 88, 1971. |
mouse |
LD50 |
intravenous |
160ug/kg (0.16mg/kg) |
|
International Journal of Neuropharmacology. Vol. 8, Pg. 131, 1969. |
mouse |
LD50 |
oral |
12340ug/kg (12.34mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 75, 1956. |
mouse |
LD50 |
subcutaneous |
280ug/kg (0.28mg/kg) |
behavioral: tremor behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: cyanosis |
Journal of Pharmacy and Pharmacology. Vol. 34, Pg. 603, 1982. |
rabbit |
LD50 |
intramuscular |
340ug/kg (0.34mg/kg) |
|
Drug and Chemical Toxicology. Vol. 3, Pg. 319, 1980. |
rabbit |
LD50 |
intravenous |
250ug/kg (0.25mg/kg) |
|
"Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 452, 1948. |
rabbit |
LD50 |
subcutaneous |
500ug/kg (0.5mg/kg) |
|
"Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 452, 1948. |
rat |
LD50 |
intravenous |
225ug/kg (0.225mg/kg) |
peripheral nerve and sensation: flaccid paralysis without anesthesia (usually neuromuscular blockage) sense organs and special senses: chromodacyrorrea: eye lungs, thorax, or respiration: structural or functional change in trachea or bronchi
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 101, Pg. 205, 1955. |